Uploaded November 2026 | Updated November 2026, 1 day ago
In early 2020, hospitals were overwhelmed and clinicians had no evidence to guide treatment for COVID-19. At the John Radcliffe Hospital in Oxford, infectious disease consultant Maheshi Ramasamy was among those enrolling patients in the RECOVERY trial – a large-scale test of existing drugs launched at unprecedented speed inside the NHS.
By June 2020, the trial confirmed that dexamethasone, a cheap, widely available steroid, could significantly reduce deaths among the most severely ill patients. The finding was applied almost immediately in clinical guidelines worldwide, and is estimated to have saved around one million lives.
Read the story: wellcome.org/insights/articles/recovery-game-changing-covid-19-treatment-trial-saved-lives
Contributors: Maheshi Ramasamy
With thanks: The RECOVERY trial was established and funded by UK Research and Innovation (UKRI) and the National Institute for Health and Care Research (NIHR). Its international expansion, launched in 2021, has been supported by a wider group of global funders, including Wellcome, the Gates Foundation, the UK Foreign, Commonwealth & Development Office, Health Data Research UK, and the Medical Research Council, alongside international research partnerships.
Health Wonders is a series from Wellcome – changing lives through science.
wellcome.org
In early 2020, hospitals were overwhelmed and clinicians had no evidence to guide treatment for COVID-19. At the John Radcliffe Hospital in Oxford, infectious disease consultant Maheshi Ramasamy was among those enrolling patients in the RECOVERY trial – a large-scale test of existing drugs launched at unprecedented speed inside the NHS.
By June 2020, the trial confirmed that dexamethasone, a cheap, widely available steroid, could significantly reduce deaths among the most severely ill patients. The finding was applied almost immediately in clinical guidelines worldwide, and is estimated to have saved around one million lives.
Read the story: wellcome.org/insights/articles/recovery-game-changing-covid-19-treatment-trial-saved-lives
Contributors: Maheshi Ramasamy
With thanks: The RECOVERY trial was established and funded by UK Research and Innovation (UKRI) and the National Institute for Health and Care Research (NIHR). Its international expansion, launched in 2021, has been supported by a wider group of global funders, including Wellcome, the Gates Foundation, the UK Foreign, Commonwealth & Development Office, Health Data Research UK, and the Medical Research Council, alongside international research partnerships.
Health Wonders is a series from Wellcome – changing lives through science.
wellcome.org










